153 related articles for article (PubMed ID: 16299248)
21. Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction.
Song N; Kim AJ; Kim HJ; Jee HJ; Kim M; Yoo YH; Yun J
J Pineal Res; 2012 Nov; 53(4):335-43. PubMed ID: 22536785
[TBL] [Abstract][Full Text] [Related]
22. Cyclin-dependent kinase inhibitor roscovitine induces cell cycle arrest and apoptosis in rabbit retinal pigment epithelial cells.
Wu PC; Tai MH; Hu DN; Lai CH; Chen YH; Wu YC; Tsai CL; Shin SJ; Kuo HK
J Ocul Pharmacol Ther; 2008 Feb; 24(1):25-33. PubMed ID: 18370874
[TBL] [Abstract][Full Text] [Related]
23. Mitogen-activated protein kinase p38 and retinoblastoma protein signalling is required for DNA damage-mediated formation of senescence-associated heterochromatic foci in tumour cells.
Zhang Y; Gao Y; Zhao L; Han L; Lu Y; Hou P; Shi X; Liu X; Tian B; Wang X; Huang B; Lu J
FEBS J; 2013 Sep; 280(18):4625-39. PubMed ID: 23859194
[TBL] [Abstract][Full Text] [Related]
24. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells.
El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH
DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797
[TBL] [Abstract][Full Text] [Related]
25. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
26. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells.
Mgbonyebi OP; Russo J; Russo IH
Cancer Res; 1999 Apr; 59(8):1903-10. PubMed ID: 10213499
[TBL] [Abstract][Full Text] [Related]
27. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
[TBL] [Abstract][Full Text] [Related]
28. A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage.
Yoon S; Kim JH; Lee YJ; Ahn MY; Choi G; Kim WK; Yang Z; Lee HJ; Moon HR; Kim HS
Eur J Pharmacol; 2012 Dec; 697(1-3):24-31. PubMed ID: 23085270
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.
N'gompaza-Diarra J; Bettayeb K; Gresh N; Meijer L; Oumata N
Eur J Med Chem; 2012 Oct; 56():210-6. PubMed ID: 22982525
[TBL] [Abstract][Full Text] [Related]
30. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
[TBL] [Abstract][Full Text] [Related]
31. R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair.
Federico M; Symonds CE; Bagella L; Rizzolio F; Fanale D; Russo A; Giordano A
Mol Cancer; 2010 Aug; 9():208. PubMed ID: 20684776
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202.
Raynaud FI; Whittaker SR; Fischer PM; McClue S; Walton MI; Barrie SE; Garrett MD; Rogers P; Clarke SJ; Kelland LR; Valenti M; Brunton L; Eccles S; Lane DP; Workman P
Clin Cancer Res; 2005 Jul; 11(13):4875-87. PubMed ID: 16000586
[TBL] [Abstract][Full Text] [Related]
33. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
34. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Abaza MS; Bahman AM; Al-Attiyah RJ
World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
[TBL] [Abstract][Full Text] [Related]
35. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
Somerville L; Cory JG
Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
[TBL] [Abstract][Full Text] [Related]
36. [Antiproliferative effect of bcl-2 gene does not concern the control of mitotic events].
Neliudova AM; Brichkina AI; Rukhlova MP; Aksenov ND; Pospelova TV
Tsitologiia; 2004; 46(3):257-67. PubMed ID: 15214171
[TBL] [Abstract][Full Text] [Related]
37. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L
Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471
[TBL] [Abstract][Full Text] [Related]
38. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model.
Appleyard MV; O'Neill MA; Murray KE; Paulin FE; Bray SE; Kernohan NM; Levison DA; Lane DP; Thompson AM
Int J Cancer; 2009 Jan; 124(2):465-72. PubMed ID: 19003963
[TBL] [Abstract][Full Text] [Related]
39. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
Motwani M; Li X; Schwartz GK
Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
[TBL] [Abstract][Full Text] [Related]
40. The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment.
Jee HJ; Kim HJ; Kim AJ; Song N; Kim M; Lee HJ; Yun J
Cancer Lett; 2013 Jul; 335(1):175-82. PubMed ID: 23416273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
